Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens

The effects of phencyclidine (PCP) on the release of acetylcholine and dopamine, stimulated by excitatory amino acid agonists was examined in slices of nucleus accumbens of the rat. In slices incubated in [3H]choline or [3H]dopamine, the amount of tritium efflux produced by 1 mM N-methyl-D-aspartate (NMDA), kainic acid (KA) or quisqualic acid (QA) was compared with that produced in the presence of varying concentrations of phencyclidine. N-Methyl-D-aspartate stimulated the calcium-dependent release of both ACh and DA, which was completely inhibited by physiological concentrations of magnesium and inhibited by 2-aminophosphonovalerate (2-APV). Kainic acid- and quisqualic acid-stimulated release of ACh and DA was partially inhibited by magnesium or by 2-APV. Phencyclidine inhibited NMDA-stimulated release of ACh and DA with IC50's around 100 nM. Phencyclidine (0.1 microM) also significantly inhibited kainic acid and quisqualic acid-induced release of ACh in magnesium-free but not magnesium-containing buffer, suggesting that the effect of PCP on kainic acid- and possibly quisqualic acid-stimulated release of ACh is on that part of the response which is mediated by NMDA receptors. The results suggest that the inhibition by PCP of the release of ACh and DA in the nucleus accumbens is selective for NMDA-type receptors.

[1]  L. Snell,et al.  Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. , 1985, The Journal of pharmacology and experimental therapeutics.

[2]  K. Johnson,et al.  Phencyclidine-induced inhibition of striatal acetylcholine release: comparisons with mu, kappa, and sigma opiate agonists. , 1984, Life sciences.

[3]  C. Pilapil,et al.  Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system. , 1985, European journal of pharmacology.

[4]  D. Lodge,et al.  The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate , 1983, British journal of pharmacology.

[5]  Kenneth M. Johnson,et al.  Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding , 1985, Pharmacology Biochemistry and Behavior.

[6]  A. Luini,et al.  Distinct pharmacological properties of excitatory amino acid receptors in the rat striatum: study by Na+ efflux assay. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[7]  O. Lindvall,et al.  Anatomy of the dopaminergic neuron systems in the rat brain. , 1978, Advances in biochemical psychopharmacology.

[8]  L. Nowak,et al.  Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.

[9]  F. Fonnum,et al.  The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat , 1979, Neuroscience.

[10]  R. H. Evans,et al.  Excitatory amino acid transmitters. , 1981, Annual review of pharmacology and toxicology.

[11]  B. Scatton,et al.  Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slices , 1982, Brain Research.

[12]  K. Jhamandas,et al.  Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid. , 1983, Canadian journal of physiology and pharmacology.

[13]  L. Snell,et al.  Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. , 1986, The Journal of pharmacology and experimental therapeutics.

[14]  M. Mayer,et al.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones , 1984, Nature.

[15]  J. Watkins,et al.  Mg2+-like selective antagonism of excitatory amino acid-induced responses by α,ε-diaminopimelic acid, D-α-maminoadipate and HA-966 in isolated spinal cord of frog and immature rat , 1978, Brain Research.

[16]  P. Roberts,et al.  STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONS , 1979, Journal of neurochemistry.

[17]  J. Coyle,et al.  Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids. , 1983, The Journal of pharmacology and experimental therapeutics.

[18]  P. Roberts,et al.  Glutamate-preferring receptors regulate the release of D-[3H]aspartate from rat hippocampal slices , 1981, Nature.

[19]  F. Fonnum,et al.  LOCALIZATION OF GABAERGIC, CHOLINERGIC AND AMINERGIC STRUCTURES IN THE MESOLIMBIC SYSTEM , 1977, Journal of neurochemistry.

[20]  I. Richardson,et al.  THE RELEASE OF LABELLED ACETYLCHOLINE AND CHOLINE FROM CEREBRAL CORTICAL SLICES STIMULATED ELECTRICALLY , 1974, British journal of pharmacology.

[21]  M. Mayer,et al.  Mg2+ dependence of membrane resistance increases evoked by NMDA in hippocampal neurones , 1984, Brain Research.